Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;71(6):2149-2159.
doi: 10.1002/hep.31226.

Nonhospice Palliative Care Within the Treatment of End-Stage Liver Disease

Affiliations
Review

Nonhospice Palliative Care Within the Treatment of End-Stage Liver Disease

Manisha Verma et al. Hepatology. 2020 Jun.

Abstract

Palliative care (PC) that has evolved from a focus on end-of-life care to an expanded form of holistic care at an early stage for patients with serious illnesses and their families is commonly referred to as nonhospice PC (or early PC). Patients with end-stage liver disease (ESLD) suffer from a high symptom burden and a deteriorated quality of life (QOL), with uncertain prognosis and limited treatment options. Caregivers of these patients also bear an emotional and physical burden similar to that of caregivers for patients with cancer. Despite the proven benefits of nonhospice PC for other serious illnesses and cancer, there are no evidence-based structures and processes to support its integration within the routine care of patients with ESLD and their caregivers. In this article, we review the current state of PC for ESLD and propose key structures and processes to integrate nonhospice PC within routine hepatology practice. Results found that PC is highly underutilized within ESLD care, and limited prospective studies are available to demonstrate methods to integrate PC within routine hepatology practices. Hepatology providers report lack of training to deliver PC along with no clear prognostic criteria on when to initiate PC. A well-informed model with key structures and processes for nonhospice PC integration would allow hepatology providers to improve clinical outcomes and QOL for patients with ESLD and reduce health care costs. Educating hepatology providers about PC principles and developing clear prognostic criteria for when and how to integrate PC on the basis of individual patient needs are the initial steps to inform the integration. The fields of nonhospice PC and hepatology have ample opportunities to partner clinically and academically.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest: Dr. Singal consults for Wako, Roche, Glycotest, Exact Sciences, Bayer, Eisai, Genentech, Bristol-Myers Squibb, Exelixis, and TARGET PharmaSolutions. Dr. Tapper consults for Allergan, Kaleido, and Axcella. He advises Bausch and Rebiotix.

References

    1. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR. Underestimation of liver-related mortality in the United States. Gastroenterology 2013;145:375–382.e1–2. - PMC - PubMed
    1. U.S. Department of Health and Human Services; Centers for Disease Control; National Center for Health Statistics. Health, United States, 2017, With Special Feature on Mortality. National Center for Health Statistics, 2018. Accessed December 4, 2019. https://www.cdc.gov/nchs/data/hus/hus17.pdf
    1. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study. BMJ 2018;362:k2817. - PMC - PubMed
    1. Peng JK, Hepgul N, Higginson IJ, Gao W. Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis. Palliat Med 2019;33:24–36. - PMC - PubMed
    1. Verma M, Horrow J, McManus K, Navarro V. Exploring the burden, unmet needs and quality of life of caregivers of patients being evaluated for liver transplant. Hepatology 2019;70(Suppl.):446A.

Publication types